| 2026-09-29 | Trial | New trial registered: A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or | Trial register ClinicalTrials.gov |
| 2026-09-29 | Trial | New trial registered: Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial | Trial register ClinicalTrials.gov |
| 2026-09-29 | Trial | New trial registered: Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients | Trial register ClinicalTrials.gov |
| 2026-09-25 | Trial | New trial registered: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight | Trial register ClinicalTrials.gov |
| 2026-09-22 | Trial | New trial registered: Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes | Trial register ClinicalTrials.gov |
| 2026-09-18 | Trial | New trial registered: Efficacy of Tirzepatide for Weight Management in Patients With Suboptimal Weight Loss After Bariatric Surgery: A Randomized, Double-Blind, Placebo-C | Trial register ClinicalTrials.gov |
| 2026-09-18 | Warning letter | FDA warning letter to Empower Clinic Services, LLC dba Empower Pharmacy: CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug | Regulator FDA warning letters |
| 2026-09-17 | Trial | New trial registered: Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder | Trial register ClinicalTrials.gov |
| 2026-09-15 | Trial | New trial registered: Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial | Trial register ClinicalTrials.gov |
| 2026-09-14 | Trial | New trial registered: Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Ag | Trial register ClinicalTrials.gov |
| 2026-09-10 | Trial | New trial registered: Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer | Trial register ClinicalTrials.gov |
| 2026-09-09 | Trial | New trial registered: Real-World Outcomes of Tirzepatide in Pakistani Adults With Obesity, Prediabetes, and Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-09-04 | Trial | New trial registered: A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity | Trial register ClinicalTrials.gov |
| 2026-09-01 | Trial | New trial registered: A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin | Trial register ClinicalTrials.gov |
| 2026-08-28 | Label | FDA label revised: Zepbound (NDA217806) | Regulator FDA drug label register |
| 2026-08-27 | Label | FDA label revised: Mounjaro (NDA215866) | Regulator FDA drug label register |
| 2026-08-24 | Trial | New trial registered: Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib | Trial register ClinicalTrials.gov |
| 2026-08-24 | Warning letter | FDA warning letter to Peptide Partners LLC: Unapproved New Drugs/Misbranded | Regulator FDA warning letters |
| 2026-08-24 | Warning letter | FDA warning letter to Royal Peptides LLC: Unapproved New Drugs/Misbranded | Regulator FDA warning letters |
| 2026-08-24 | Warning letter | FDA warning letter to TXP Innovations LLC dba Tex Peptides: Unapproved New Drugs/Misbranded | Regulator FDA warning letters |
| 2026-08-20 | Trial | New trial registered: Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide | Trial register ClinicalTrials.gov |
| 2026-08-18 | Trial | New trial registered: GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry | Trial register ClinicalTrials.gov |
| 2026-08-10 | Trial | New trial registered: Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008) | Trial register ClinicalTrials.gov |
| 2026-08-07 | Trial | New trial registered: Comparing Facial Aging Between Identical Twins With 3D Imaging | Trial register ClinicalTrials.gov |
| 2026-08-05 | Trial | New trial registered: Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics | Trial register ClinicalTrials.gov |
| 2026-08-05 | Trial | New trial registered: GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD | Trial register ClinicalTrials.gov |
| 2026-07-31 | Trial | New trial registered: Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Pa | Trial register ClinicalTrials.gov |
| 2026-07-31 | Trial | New trial registered: Tirzepatide Impact Assessment Study | Trial register ClinicalTrials.gov |
| 2026-07-29 | Federal Register | Federal Register notice: Product-Specific Guidances; Revised Draft Guidances for Industry; Availability | Regulator Federal Register |
| 2026-07-29 | Label | FDA label revised: MOUNJARO (NDA215866) | Regulator FDA drug label register |
| 2026-07-29 | Label | FDA label revised: MOUNJARO (NDA215866) | Regulator FDA drug label register |
| 2026-07-29 | Label | FDA label revised: MOUNJARO (NDA215866) | Regulator FDA drug label register |
| 2026-07-29 | Label | FDA label revised: MOUNJARO (NDA215866) | Regulator FDA drug label register |
| 2026-07-29 | Label | FDA label revised: MOUNJARO (NDA215866) | Regulator FDA drug label register |
| 2026-07-29 | Label | FDA label revised: MOUNJARO (NDA215866) | Regulator FDA drug label register |
| 2026-07-29 | Trial | New trial registered: Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial | Trial register ClinicalTrials.gov |
| 2026-07-29 | Trial | New trial registered: Tirzepatide for Treatment of CCCA | Trial register ClinicalTrials.gov |
| 2026-07-27 | Trial | New trial registered: Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients | Trial register ClinicalTrials.gov |
| 2026-07-21 | Trial | New trial registered: Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients | Trial register ClinicalTrials.gov |
| 2026-07-17 | Trial | New trial registered: Effects of GLP-1 RAs on Human Lactation Outcomes | Trial register ClinicalTrials.gov |
| 2026-07-16 | Trial | New trial registered: Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV | Trial register ClinicalTrials.gov |
| 2026-07-15 | Trial | New trial registered: Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy | Trial register ClinicalTrials.gov |
| 2026-07-14 | Trial | New trial registered: Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists | Trial register ClinicalTrials.gov |
| 2026-07-14 | Trial | New trial registered: Salivary Function and Dental Changes During GLP-1 Therapy | Trial register ClinicalTrials.gov |
| 2026-07-14 | Trial | New trial registered: Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity | Trial register ClinicalTrials.gov |
| 2026-07-13 | Trial | New trial registered: AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-07-13 | Trial | New trial registered: High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE) | Trial register ClinicalTrials.gov |
| 2026-07-10 | Trial | New trial registered: Pragmatic Trial to Study the Cost-Effectiveness of MyPhenome-RX Test to Guide Anti-Obesity Pharmacotherapy | Trial register ClinicalTrials.gov |
| 2026-07-09 | Trial | New trial registered: An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder | Trial register ClinicalTrials.gov |
| 2026-07-08 | Results | Results posted: A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-07-06 | Trial | New trial registered: Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss | Trial register ClinicalTrials.gov |
| 2026-07-02 | Results | Results posted: Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists | Trial register ClinicalTrials.gov |
| 2026-06-30 | Trial | New trial registered: Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial | Trial register ClinicalTrials.gov |
| 2026-06-26 | Federal Register | Federal Register notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comm | Regulator Federal Register |
| 2026-06-26 | Trial | New trial registered: Tirzepatide in the Treatment of Cannabis Use Disorder | Trial register ClinicalTrials.gov |
| 2026-06-26 | Trial | New trial registered: A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Part | Trial register ClinicalTrials.gov |
| 2026-06-24 | Trial | New trial registered: GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation | Trial register ClinicalTrials.gov |
| 2026-06-17 | Trial | New trial registered: Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists. | Trial register ClinicalTrials.gov |
| 2026-06-10 | Trial | New trial registered: Genetic, Microbiological and Behavioral Factors in Obesity | Trial register ClinicalTrials.gov |
| 2026-06-10 | Trial | New trial registered: Tirzepatide-Based Prehabilitation Before Elective Ventral and Incisional Hernia Repair in Patients With Obesity | Trial register ClinicalTrials.gov |
| 2026-06-08 | Trial | New trial registered: GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity | Trial register ClinicalTrials.gov |
| 2026-06-08 | Warning letter | FDA warning letter to Altru Telehealth, LLC dba Altru Telehealth: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Amie Health, Inc. dba Amie: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Clover Meds LLC dba Clover Meds: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to D&H Medical Services: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Eden Health International Inc. dba Eden: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Ezra Holdco LLC dba Ezra: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to FITISH: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to FitRX, LLC dba AM RX: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Glow Medispa, LLC dba Mint Med: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to HydraMed IV LLC dba HydraMed: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Joi and Blokes dba Joi + Blokes: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Maximus Health, Inc. dba Maximus: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Medica Weight Loss: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Momentum Health 360 dba Momentum Health: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to NativeMed LLC dba NativeMed: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Nexlife Inc. dba Nexlife: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Nexus Health Solutions LLC dba Harper Meds: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Nova Vascular LLC dba NOVARX: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to OrderlyMeds LLC dba OrderlyMeds: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Public Health Solution LLC dba DrMedHealth: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Ready Med: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to Trinity HealthCare Supply, LLC dba altRx: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-08 | Warning letter | FDA warning letter to VivioMD Group LLC dba VivioMD: False & Misleading Claims/Misbranded (Telehealth) | Regulator FDA warning letters |
| 2026-06-05 | Trial | New trial registered: Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF | Trial register ClinicalTrials.gov |
| 2026-06-04 | Trial | New trial registered: GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity | Trial register ClinicalTrials.gov |
| 2026-06-03 | Trial | New trial registered: Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass Surgery | Trial register ClinicalTrials.gov |
| 2026-06-03 | Trial | New trial registered: Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes | Trial register ClinicalTrials.gov |
| 2026-06-03 | Trial | New trial registered: New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-06-02 | Trial | New trial registered: Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes. | Trial register ClinicalTrials.gov |
| 2026-05-22 | Trial | New trial registered: Multi-Site Trial of Tirzepatide for Smoking Cessation | Trial register ClinicalTrials.gov |
| 2026-05-22 | Trial | New trial registered: Tirzepatide in the Treatment of Endometrial Cancer | Trial register ClinicalTrials.gov |
| 2026-05-18 | Trial | New trial registered: Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists | Trial register ClinicalTrials.gov |
| 2026-05-15 | Trial | New trial registered: GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study | Trial register ClinicalTrials.gov |
| 2026-05-15 | Trial | New trial registered: Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs | Trial register ClinicalTrials.gov |
| 2026-05-14 | Trial | New trial registered: Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. | Trial register ClinicalTrials.gov |
| 2026-05-08 | Trial | New trial registered: Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity | Trial register ClinicalTrials.gov |
| 2026-05-07 | Trial | New trial registered: Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion | Trial register ClinicalTrials.gov |
| 2026-05-05 | Trial | New trial registered: CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry | Trial register ClinicalTrials.gov |
| 2026-05-01 | Federal Register | Federal Register notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act | Regulator Federal Register |